130 related articles for article (PubMed ID: 12379652)
1. Genetic selection of peptide inhibitors of human immunodeficiency virus type 1 Vpr.
Yao XJ; Lemay J; Rougeau N; Clément M; Kurtz S; Belhumeur P; Cohen EA
J Biol Chem; 2002 Dec; 277(50):48816-26. PubMed ID: 12379652
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae.
Yao XJ; Rougeau N; Duisit G; Lemay J; Cohen EA
Retrovirology; 2004 Aug; 1():21. PubMed ID: 15312229
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
Forget J; Yao XJ; Mercier J; Cohen EA
J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection.
Hrimech M; Yao XJ; Bachand F; Rougeau N; Cohen EA
J Virol; 1999 May; 73(5):4101-9. PubMed ID: 10196306
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.
Zhu Y; Gelbard HA; Roshal M; Pursell S; Jamieson BD; Planelles V
J Virol; 2001 Apr; 75(8):3791-801. PubMed ID: 11264368
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae.
Macreadie IG; Thorburn DR; Kirby DM; Castelli LA; de Rozario NL; Azad AA
FEBS Lett; 1997 Jun; 410(2-3):145-9. PubMed ID: 9237618
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe.
Zhang C; Rasmussen C; Chang LJ
Virology; 1997 Mar; 230(1):103-12. PubMed ID: 9126266
[TBL] [Abstract][Full Text] [Related]
8. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.
Macreadie IG; Castelli LA; Hewish DR; Kirkpatrick A; Ward AC; Azad AA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2770-4. PubMed ID: 7708721
[TBL] [Abstract][Full Text] [Related]
9. The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest.
Goh WC; Manel N; Emerman M
Virology; 2004 Jan; 318(1):337-49. PubMed ID: 14972559
[TBL] [Abstract][Full Text] [Related]
10. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells.
Bolton DL; Lenardo MJ
J Virol; 2007 Sep; 81(17):8878-90. PubMed ID: 17553871
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
[TBL] [Abstract][Full Text] [Related]
12. A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle.
Nishizawa M; Myojin T; Nishino Y; Nakai Y; Kamata M; Aida Y
Virology; 1999 Oct; 263(2):313-22. PubMed ID: 10544105
[TBL] [Abstract][Full Text] [Related]
13. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.
Mansky LM; Preveral S; Le Rouzic E; Bernard LC; Selig L; Depienne C; Benarous R; Benichou S
Virology; 2001 Mar; 282(1):176-85. PubMed ID: 11259200
[TBL] [Abstract][Full Text] [Related]
14. Yeast perspectives on HIV-1 VPR.
Zhao Y; Elder RT
Front Biosci; 2000 Dec; 5():D905-16. PubMed ID: 11102318
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of growth arrest and cellular localization of human immunodeficiency virus type 1 Vpr in the budding yeast, Saccharomyces cerevisiae.
Nakazawa J; Watanabe N; Imoto M; Osada H
J Gen Appl Microbiol; 2005 Aug; 51(4):245-56. PubMed ID: 16205032
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.
Stewart SA; Poon B; Jowett JB; Chen IS
J Virol; 1997 Jul; 71(7):5579-92. PubMed ID: 9188632
[TBL] [Abstract][Full Text] [Related]
17. DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest.
Tan L; Ehrlich E; Yu XF
J Virol; 2007 Oct; 81(19):10822-30. PubMed ID: 17626091
[TBL] [Abstract][Full Text] [Related]
18. Studies with GFP-Vpr fusion proteins: induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization.
Waldhuber MG; Bateson M; Tan J; Greenway AL; McPhee DA
Virology; 2003 Aug; 313(1):91-104. PubMed ID: 12951024
[TBL] [Abstract][Full Text] [Related]
19. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells.
Yao XJ; Mouland AJ; Subbramanian RA; Forget J; Rougeau N; Bergeron D; Cohen EA
J Virol; 1998 Jun; 72(6):4686-93. PubMed ID: 9573232
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.
Terada Y; Yasuda Y
Mol Cell Biol; 2006 Nov; 26(21):8149-58. PubMed ID: 16923959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
